As a result, CD8+CD103+ TILS were strongly associated with increased OS, DSS and/or RFS in most cancer types, including urothelial cell carcinoma and ovarian, cervical, endometrial, breast, colorectal, gastric, and head and neck cancer [13, 47–61]. This evidence concerns the gene CD8A and cancer.